Literature DB >> 153122

Huntington's dementia. Clinical and neuropsychological features.

E D Caine, R D Hunt, H Weingartner, M H Ebert.   

Abstract

The neuropsychiatric syndrome of Huntington's disease is outlined in this report with an emphasis on the cognitive deficits that lend themselves to future neurobehavioral research. Eighteen patients without disabling cognitive or psychiatric symptoms were evaluated for a period of 3 to 15 weeks, with assessment of their cognitive disorder, psychiatric, and neurological symptoms. Neuropsychological examination included repeated mental status examination, the Wechsler Adult Intelligence Scale (WAIS), and, for some, parietal lobe testing. In addition to suffering from a loss of finely detailed memories, patients demonstrated impaired organizing, sequencing, planning, and recalling of information on request. On the WAIS, mean verbal and performance scores were not significantly different. Neuropsychological findings suggested that the Huntington's disease pattern of cognitive impairment is not initially diffuse and homogeneous, but characterized by a relative sparing of several higher cortical functions. Many patients had increased irritability and labile affect. The similarity of Huntington's disease to frontal lobe syndromes is also discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 153122     DOI: 10.1001/archpsyc.1978.01770270127013

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  18 in total

Review 1.  Executive control functions in degenerative dementias: a comparative review.

Authors:  L M Duke; A W Kaszniak
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

2.  Visual processing disorders in patients with Huntington's disease and asymptomatic carriers.

Authors:  E Gómez-Tortosa; A del Barrio; T Barroso; P J García Ruiz
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

3.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

4.  The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.

Authors:  Juliana G Doria; Jessica M de Souza; Flavia R Silva; Isabella G Olmo; Toniana G Carvalho; Juliana Alves-Silva; Talita H Ferreira-Vieira; Jessica T Santos; Claudymara Q S Xavier; Nathalia C Silva; Esther M A Maciel; Peter Jeffrey Conn; Fabiola M Ribeiro
Journal:  J Neurochem       Date:  2018-09-11       Impact factor: 5.372

5.  Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Authors:  Guerry M Peavy; Mark W Jacobson; Jody L Goldstein; Joanne M Hamilton; Amy Kane; Anthony C Gamst; Stephanie L Lessig; J C Lee; Jody Corey-Bloom
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

6.  Is the syndrome of pathological laughing and crying a manifestation of pseudobulbar palsy?

Authors:  W T Asfora; A A DeSalles; M Abe; R N Kjellberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

7.  Prefrontal cortical blood flow and cognitive function in Huntington's disease.

Authors:  D R Weinberger; K F Berman; M Iadarola; N Driesen; R F Zec
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

8.  Phaeochromocytoma as a cause of reversible dementia.

Authors:  P D White; W A Lishman; M A Wyke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

9.  Huntington's disease and leprosy in a New Guinea Highlander.

Authors:  E M Scrimgeour
Journal:  J Med Genet       Date:  1983-12       Impact factor: 6.318

10.  Cortical and striatal neurone number in Huntington's disease.

Authors:  H Heinsen; M Strik; M Bauer; K Luther; G Ulmar; D Gangnus; G Jungkunz; W Eisenmenger; M Götz
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.